Osaic Holdings
ASND icon

Osaic Holdings’s Ascendis Pharma A/S ASND Stock Holding History

Osaic Holdings’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
550
+220
+67% +$51.4K ﹤0.01% 4669
2026
Q1 		$75.5K Sell
330
-810
-71% -$182K ﹤0.01% 4884
2025
Q4 		$243K Sell
1,140
-179
-14% -$37K ﹤0.01% 3992
2025
Q3 		$261K Buy
1,319
+995
+307% +$186K ﹤0.01% 3994
2025
Q2 		$55.9K Sell
324
-12
-4% -$1.96K ﹤0.01% 4969
2025
Q1 		$52.4K Sell
336
-1,568
-82% -$224K ﹤0.01% 4681
2024
Q4 		$262K Buy
1,904
+1,131
+146% +$149K ﹤0.01% 3359
2024
Q3 		$115K Buy
773
+394
+104% +$53.2K ﹤0.01% 4121
2024
Q2 		$51.7K Sell
379
-11,946
-97% -$1.63M ﹤0.01% 4654
2024
Q1 		$1.86M Buy
12,325
+11,456
+1,318% +$1.64M ﹤0.01% 1750
2023
Q4 		$109K Sell
869
-293
-25% -$29.2K ﹤0.01% 4376
2023
Q3 		$109K Sell
1,162
-122
-10% -$11.4K ﹤0.01% 4439
2023
Q2 		$115K Buy
1,284
+267
+26% +$23.2K ﹤0.01% 4331
2023
Q1 		$109K Buy
1,017
+155
+18% +$17.7K ﹤0.01% 4375
2022
Q4 		$105K Sell
862
-87
-9% -$10.1K ﹤0.01% 4393
2022
Q3 		$99K Buy
949
+78
+9% +$7.39K ﹤0.01% 4384
2022
Q2 		$81K Buy
871
+220
+34% +$20.7K ﹤0.01% 4580
2022
Q1 		$76K Sell
651
-25
-4% -$2.9K ﹤0.01% 4782
2021
Q4 		$91K Sell
676
-1,304
-66% -$194K ﹤0.01% 4660
2021
Q3 		$315K Sell
1,980
-115
-5% -$15.7K ﹤0.01% 3499
2021
Q2 		$275K Sell
2,095
-17
-0.8% -$2.27K ﹤0.01% 3596
2021
Q1 		$272K Buy
2,112
+271
+15% +$41.2K ﹤0.01% 3468
2020
Q4 		$308K Buy
1,841
+112
+6% +$18.5K ﹤0.01% 3097
2020
Q3 		$266K Buy
1,729
+324
+23% +$46.6K ﹤0.01% 2986
2020
Q2 		$207K Buy
1,405
+1,302
+1,264% +$179K ﹤0.01% 3109
2020
Q1 		$11K Buy
+103
New +$13.4K ﹤0.01% 4935

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Osaic Holdings's ASND Position: Q2 2026 in Review

Osaic Holdings increased its Ascendis Pharma A/S (ASND) stake by 67% in Q2 2026, buying an estimated $51.4K and bringing the position to 550 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #4669.

Osaic Holdings first reported a position in ASND in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.86M in Q1 2024. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Osaic Holdings held 550 shares of Ascendis Pharma A/S worth $147K as of Q2 2026.
  • Osaic Holdings bought 220 Ascendis Pharma A/S shares in Q2 2026, an estimated $51.4K.
  • Ascendis Pharma A/S made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4669 holding.
  • Osaic Holdings first reported a position in Ascendis Pharma A/S in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Ascendis Pharma A/S position peaked at $1.86M in Q1 2024.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.